Clinical Trials Directory

Trials / Terminated

TerminatedNCT04724681

Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
97 (actual)
Sponsor
University Hospital Bispebjerg and Frederiksberg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

For patients admitted with COVID-19 infection, it is often difficult to predict if or when their clinical condition will deteriorate. However subtle changes in vital signs are usually present 8 to 24 hours before a life-threatening event such as respiratory failure leading to ICU admission, or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed, misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital parameter monitoring systems offer a unique possibility to identify clinical deterioration before patients condition progress beyond the point-of-no-return, where adverse events are inevitable. The primary aim of this study is to test the effect of continuous wireless vital signs monitoring with generation of real-time alerts through a purpose-built GUI, compared to standard EWS monitoring on the cumulative duration of any severely deviating vital signs

Conditions

Interventions

TypeNameDescription
DEVICEWARD CSSWireless devices monitor vital signs continuously and transmit real-time data to an app that notifies clinical personnel when relevant deviations in vital signs occur This group will be monitored with standard Early Warning Score as well

Timeline

Start date
2020-11-03
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2021-01-26
Last updated
2023-06-01

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04724681. Inclusion in this directory is not an endorsement.